Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL472068 | 1.00 | CA1 (0.38) | CA1CA2CA7TSHRLMNA | |
| SCHEMBL6600382 | 1.00 | CA1 (0.38) | CA1CA2CA7TSHRLMNA | |
| 1,6-Hexanediol SCHEMBL472147 | 1.00 | CA1 (0.38) | CA1CA2CA7TSHRLMNA | |
| SCHEMBL6599869 | 1.00 | CA1 (0.38) | CA1CA2CA7TSHRLMNA | |
| 1,5-Pentanediol SCHEMBL472091 | 1.00 | CA1 (0.38) | CA1CA2CA7TSHRLMNA | |
| 1,4-Butanediol SCHEMBL865857 | 0.97 | CA1 (0.39) | CA1CA2CA7TSHRLMNA | |
| Butadiene SCHEMBL27545001 | 0.95 | CA1 (0.35) | CA1CA2CA7TSHRLMNA | |
| SCHEMBL27518172 | 0.93 | CA1 (0.34) | CA1CA2CA7TSHRLMNA | |
| 1,3-Propanediol SCHEMBL1773540 | 0.92 | CA1 (0.39) | CA1CA2CA7TSHRALDH1A1 | |
| Dodecanol SCHEMBL28619410 | 0.89 | TSHR (0.56) | TSHRLMNAALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9701874-B2 | Conductive adhesive, anisotropic conductive film, and electronic device using same | SHOWA DENKO K.K. (JP) | 2017-07-11 | — | — | US | claimed |
| EP-2982727-B1 | CONDUCTIVE ADHESIVE, ANISOTROPIC CONDUCTIVE FILM AND ELECTRONIC DEVICES USING BOTH | SHOWA DENKO KK (JP) | 2020-09-02 | — | — | EP | disclosed |
| US-9701874-B2 | Conductive adhesive, anisotropic conductive film, and electronic device using same | SHOWA DENKO K.K. (JP) | 2017-07-11 | — | — | US | disclosed |
| US-20160060490-A1 | CONDUCTIVE ADHESIVE, ANISOTROPIC CONDUCTIVE FILM AND ELECTRONIC DEVICES USING BOTH | SHOWA DENKO K.K. (JP) | 2016-03-03 | — | — | US | disclosed |
| EP-2982727-A1 | CONDUCTIVE ADHESIVE, ANISOTROPIC CONDUCTIVE FILM AND ELECTRONIC DEVICES USING BOTH | Showa Denko K.K. (JP) | 2016-02-10 | — | — | EP | disclosed |
| US-8759553-B2 | Method for producing epoxy compound | SHOWA DENKO K.K. (JP) | 2014-06-24 | — | — | US | disclosed |
| US-8664414-B2 | Process for producing epoxy compound | SHOWA DENKO K.K. (JP) | 2014-03-04 | — | — | US | disclosed |
| US-20130116455-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | SHOWA DENKO K.K. (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20120029217-A1 | PROCESS FOR PRODUCING EPOXY COMPOUND | SHOWA DENKO K.K. (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-2412712-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | Showa Denko K.K. (JP) | 2012-02-01 | — | — | EP | disclosed |
| EP-1046078-B1 | LIQUID CRYSTAL DEVICE ALIGNMENT AND METHOD OF MAKING SUCH A DEVICE | HEWLETT PACKARD CO (US) | 2004-05-12 | — | — | EP | disclosed |
| US-6727968-B1 | Liquid crystal device alignment | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2004-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029217-A1 | PROCESS FOR PRODUCING EPOXY COMPOUND | NOX4, NOX5, NOXO1 | CA1 606/4885CA2 416/4885CA7 564/4885 |
| US-20130116455-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | DUOX2, EPHX2, AOX1 | CA1 112/4885CA2 264/4885CA7 342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.